Announcements
Cannabis Market Intelligence For Executives & Investors
Daily Briefing
May 13, 2026
Indiana: GOP Lawmaker Reveals Early Plan To Legalize Medical Marijuana For 2027 Session
Indiana State Sen. Mike Bohacek is preparing 2027 legislation to legalize medical cannabis, proposing a tightly regulated system for patient...
May 13, 2026
Texas Reworks Medical Cannabis Licensing, Sends This Cannabis Giant To Backup Pool
Texas has revised its medical cannabis licensing process, resulting in Cresco Labs losing a previously awarded conditional license and being...
May 13, 2026
Jushi Q1 2026 Earnings: Revenue And Margins Improve, But Net Loss Widens
Jushi Holdings reported higher first-quarter 2026 revenue and improved operational profitability as wholesale growth and retail expansion supported margin expansion....
Announcements
May 7, 2026
Trulieve Cannabis Corp. to Hold First Quarter 2026 Results Conference Call on May 7, 2026
April 27, 2026
DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know
April 27, 2026
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
Chicago
Cannabis Conference
June 14-16, 2026
Chicago Capital Cannabis Conference
IgniteIt Cannabis
IgniteIt Psydelecis
May 13, 2026
Exclusive: Attorneys Break Down What’s Next In The Fight Over CMS’ CBD Pilot Program
May 12, 2026
This Cannabis Co. Secures $9.3M In Oversubscribed Financing, Here’s Where The Capital Will Go
May 12, 2026
New Hemp THC Rules Could Disrupt Luxury CBD Spa Treatments At Top Resorts
May 12, 2026
Could Medical Cannabis Finally Cross State Lines? Attorneys Break Down Schedule III’s Biggest Legal Question
May 11, 2026
Village Farms Cannabis Co Sees Strong Start To 2026 With Revenue And Margin Gains
May 9, 2026
DEA Registration, 280E Relief, and State Rules Top Concerns After Rescheduling Order
May 8, 2026
Cresco Labs Bets On Cannabis Rescheduling, Q1 Revenue And Profitability Weaken
May 7, 2026
Green Thumb Industries Q1 Revenue Rises 7.4% YoY On Strong State Sales, Net Income Doubles
May 7, 2026
TerrAscend Reports Q1 2026 Revenue Growth, Positive Free Cash Flow, Net Loss Widens
May 7, 2026
ACE Venture Acquires 51% of Vireo New York and Debuts Boukét Brand
May 7, 2026
Trulieve Swings To Profit In Q1, Expands Florida Operations As DEA Cannabis Hearing Nears
May 7, 2026
Target Bets Big On Hemp Beverages With Rollout In These Three States Despite Regulatory Uncertainty
May 7, 2026
Exclusive: Alcohol Industry Tells Congress Its Model Can Support Hemp Regulation
May 6, 2026
Federal Tax Guidance for State-Licensed Medical Cannabis Companies Is Coming, Treasury Says
May 6, 2026
Exclusive: California Rolls Out New Guidance to Help Cannabis Businesses Prepare for Federal Rescheduling
New Jersey Cannabis Market Spotlight
Click on the upper right section of the video to navigate the full playlist
Interviews
May 14, 2026
Google, Meta, and Broadcast TV Could Open To Cannabis Advertising Under Schedule III
As medical cannabis moves to Schedule III, advertisers face a shifting landscape that could expand access to mainstream media while...
May 13, 2026
Exclusive: Attorneys Break Down What’s Next In The Fight Over CMS’ CBD Pilot Program
Cannabis attorneys break down the high-stakes legal fight over CMS’ CBD pilot program as a federal court weighs whether the...
May 12, 2026
Could Medical Cannabis Finally Cross State Lines? Attorneys Break Down Schedule III’s Biggest Legal Question
Federal rescheduling has revived long-standing questions about whether medical cannabis can finally move across state lines, and attorneys say the...
May 9, 2026
DEA Registration, 280E Relief, and State Rules Top Concerns After Rescheduling Order
The shift to Schedule III opens the door to tax relief and expanded banking access, but attorneys warn that DEA...
May 8, 2026
Verano CIO Aaron Miles On Margin Compression, Texas Expansion, Schedule III, and Why He Believes Cannabis Is “A Slam Dunk”
Aaron Miles discusses Verano’s strategy around cannabis margin compression, Texas expansion, wholesale stabilization, Schedule III reform and the company’s $20...
May 8, 2026
Tilray CEO Says Schedule III Marks A Turning Point For U.S. Medical Cannabis
The Trump administration’s decision to reclassify state‑legal medical cannabis as a Schedule III substance marks the most significant shift in...
Deals
May 6, 2026
Cannabis M&A Heats Up As FLUENT Offloads Texas Business In $30M Deal
May 1, 2026
Cannabis M&A Accelerates as Curaleaf Deepens Europe Expansion and Vireo Expands in Florida
April 21, 2026
Missouri Bets On Marijuana Research As It Opens Unlimited Licensing Pathway
April 16, 2026
Decibel Cannabis Stock Up After Strong 2025 Results, 484% YoY International Sales Growth
April 16, 2026
Curaleaf Rolls Out $83M Buyback Plan Ahead Of Q1 Results
April 15, 2026
Only 0.1% of the UK has a Cannabis Prescription, Tilray Just Bought Into the Other 99.9%
Announcements
View All
April 27, 2026
DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know
April 27, 2026
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
April 27, 2026
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
News
View All
April 29, 2026
New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development
April 24, 2026
420 Sales Spike 2.5× in 2026 as Dutchie’s New Dashboard Highlights Deal-Driven Demand
April 23, 2026
Medical Cannabis Stocks Volatile on Trump Reclassification Move
April 22, 2026
Marijuana Use Under Scrutiny In New Medicaid Cost And Health Impact GOP-Backed Bill
April 22, 2026
Cannabis Stocks Surge As Trump Administration Signals Marijuana Reclassification
April 21, 2026
Is This Red State Turning Purple? Democrat Gov. Candidate Makes Marijuana Reform A Campaign Issue
April 21, 2026
Missouri Bets On Marijuana Research As It Opens Unlimited Licensing Pathway
Real-Time Cannabis Intelligence That Moves Capital
IGNITE IT delivers institutional-grade cannabis market intelligence in real time. From breaking news and regulatory shifts to capital flows and operator performance, we surface the data that serious investors and decision-makers need before the market reacts.
Built for speed, accuracy, and clarity, our platform cuts through noise and eliminates information gaps in one of the fastest-moving industries in the world.
View Insights
Where Industry Expertise Meets Market Momentum
Backed by seasoned financial journalists, cannabis industry veterans, and media leaders, IGNITE IT combines deep sector expertise with real-time analysis. We don’t just report market activity, we contextualize it so decision-makers can act with confidence.
Beyond intelligence, IGNITE IT connects the industry through high-impact events that bring capital, operators, and innovators into the same room.
Explore Events
